202 related articles for article (PubMed ID: 22581816)
1. Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention.
Evans DG; Warwick J; Astley SM; Stavrinos P; Sahin S; Ingham S; McBurney H; Eckersley B; Harvie M; Wilson M; Beetles U; Warren R; Hufton A; Sergeant JC; Newman WG; Buchan I; Cuzick J; Howell A
Cancer Prev Res (Phila); 2012 Jul; 5(7):943-51. PubMed ID: 22581816
[TBL] [Abstract][Full Text] [Related]
2. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.
Evans DG; Brentnall AR; Harvie M; Dawe S; Sergeant JC; Stavrinos P; Astley S; Wilson M; Ainsworth J; Cuzick J; Buchan I; Donnelly LS; Howell A
Cancer Prev Res (Phila); 2014 Oct; 7(10):993-1001. PubMed ID: 25047362
[TBL] [Abstract][Full Text] [Related]
4. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
van Veen EM; Brentnall AR; Byers H; Harkness EF; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
JAMA Oncol; 2018 Apr; 4(4):476-482. PubMed ID: 29346471
[TBL] [Abstract][Full Text] [Related]
5. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
7. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
[TBL] [Abstract][Full Text] [Related]
8. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk feedback to women in the UK NHS breast screening population.
Evans DG; Donnelly LS; Harkness EF; Astley SM; Stavrinos P; Dawe S; Watterson D; Fox L; Sergeant JC; Ingham S; Harvie MN; Wilson M; Beetles U; Buchan I; Brentnall AR; French DP; Cuzick J; Howell A
Br J Cancer; 2016 Apr; 114(9):1045-52. PubMed ID: 27022688
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
Loehberg CR; Jud SM; Haeberle L; Heusinger K; Dilbat G; Hein A; Rauh C; Dall P; Rix N; Heinrich S; Buchholz S; Lex B; Reichler B; Adamietz B; Schulz-Wendtland R; Beckmann MW; Fasching PA
Breast Cancer Res Treat; 2010 May; 121(1):101-10. PubMed ID: 20306293
[TBL] [Abstract][Full Text] [Related]
11. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
[TBL] [Abstract][Full Text] [Related]
12. Preliminary investigation of mammographic density among women in Riyadh: association with breast cancer risk factors and implications for screening practices.
Albeshan SM; Hossain SZ; Mackey MG; Peat JK; Al Tahan FM; Brennan PC
Clin Imaging; 2019; 54():138-147. PubMed ID: 30639525
[TBL] [Abstract][Full Text] [Related]
13. Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study.
Thompson DJ; Leach MO; Kwan-Lim G; Gayther SA; Ramus SJ; Warsi I; Lennard F; Khazen M; Bryant E; Reed S; Boggis CR; Evans DG; Eeles RA; Easton DF; Warren RM;
Breast Cancer Res; 2009; 11(6):R80. PubMed ID: 19903338
[TBL] [Abstract][Full Text] [Related]
14. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
15. Mammographic features and breast cancer risk: effects with time, age, and menopause status.
Byrne C; Schairer C; Wolfe J; Parekh N; Salane M; Brinton LA; Hoover R; Haile R
J Natl Cancer Inst; 1995 Nov; 87(21):1622-9. PubMed ID: 7563205
[TBL] [Abstract][Full Text] [Related]
16. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
[TBL] [Abstract][Full Text] [Related]
17. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Andersson I; Aspegren K; Janzon L; Landberg T; Lindholm K; Linell F; Ljungberg O; Ranstam J; Sigfússon B
BMJ; 1988 Oct; 297(6654):943-8. PubMed ID: 3142562
[TBL] [Abstract][Full Text] [Related]
18. Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: short-term results of a pilot study in 40-49-year-old women.
Venturini E; Losio C; Panizza P; Rodighiero MG; Fedele I; Tacchini S; Schiani E; Ravelli S; Cristel G; Panzeri MM; De Cobelli F; Del Maschio A
Radiology; 2013 Aug; 268(2):347-55. PubMed ID: 23579052
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
